Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage

Nephrology Dialysis Transplantation

Volumn 24, Issue 2, 2009, Pages 413-420

  Ochodnicky, Peter ^a,b   Henning, Robert H ^a   Buikema, Hendrik ^a   Kluppel, Alex C A ^a   Van Wattum, Marjolein ^a   De Zeeuw, Dick ^a   Van Dokkum, Richard P E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Physics and Informatics   (Slovakia)

Author keywords

Adriamycin nephrosis; Endothelial function; Nitric oxide; Predictive value proteinuria; Renal blood flow

Indexed keywords

ACETYLCHOLINE; DOXORUBICIN; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY PLASMA FLOW; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; DISEASE SUSCEPTIBILITY; DOXORUBICIN; ENDOTHELIUM, VASCULAR; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; RATS; RATS, WISTAR; RENAL CIRCULATION; RENAL PLASMA FLOW, EFFECTIVE;

EID: 58449101298     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn483     Document Type: Article

References (31)

1. Levey AS, Coresh J, Balk E et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
2. Provoost AP. Spontaneous glomerulosclerosis: insights from the fawn-hooded rat. Kidney Int Suppl 1994; 45: S2-S5
3. Schulz A, Litfin A, Kossmehl P et al. Genetic dissection of increased urinary albumin excretion in the Munich Wistar Fromter rat. J Am Soc Nephrol 2002; 13: 2706-2714
4. Bowden DW. Genetics of kidney disease. Kidney Int Suppl 2003; S8-S12
5. Gretz N, Waldherr R, Strauch M. The remnant kidney model. In: Gretz N, Strauch M (eds.). Experimental and Genetic Models of Chronic Renal Failure. Basel, Switzerland: Karger, 1993, 1-28
6. Gschwend S, Buikema H, Navis G et al. Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat. J Am Soc Nephrol 2002; 13: 2909-2915
7. Bertani T, Poggi A, Pozzoni R et al. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 1982; 46: 16-23
8. Okuda S, Oh Y, Tsuruda H et al. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986; 29: 502-510
9. Rook M, Lely AT, Kramer A et al. Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage. Nephrol Dial Transplant 2005; 20: 59-64
10. de Boer E, Navis G, Tiebosch AT et al. Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats. J Am Soc Nephrol 1999; 10: 2359-2366
11. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 1997; 30: 311-333
12. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004; 24: 354-365
13. Ozen S, Usta Y, Sahin-Erdemli I et al. Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant 2001; 16: 32-38
14. Van Dokkum RP, Eijkelkamp WB, Kluppel AC et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 2004; 15: 3103-3110
15. Marcel de Vries PA, Navis G, de Boer E et al. A method for accurate measurement of GFR in conscious, spontaneously voiding rats. Kidney Int 1997; 52: 244-247
16. Bell RR, Bombardt PA, DuCharme DW et al. A non-radioactive iothalamate and p-aminohippuric acid high-performance liquid chromatographic method for simultaneously measuring glomerular filtration rate and renal blood flow in the rat. Biomed Chromatogr 1994; 8: 224-229
17. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992
18. Halcox JP, Schenke WH, Zalos G et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658
19. Hostetter TH. Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995; 57: 263-278
20. Baylis C, Qiu C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int 1996; 49: 1727-1731
21. Beierwaltes WH, Sigmon DH, Carretero OA. Endothelium modulates renal blood flow but not autoregulation. Am J Physiol 1992; 262: F943-F949
22. Johansen PB, Jensen SE, Rasmussen SN et al. Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine. Cancer Chemother Pharmacol 1984; 13: 5-8
23. Garner AP, Paine MJ, Rodriguez-Crespo I et al. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents. Cancer Res 1999; 59: 1929-1934
24. Blantz RC, Munger K. Role of nitric oxide in inflammatory conditions. Nephron 2002; 90: 373-378
25. Majid DS, Navar LG. Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens 2001; 14: 74S-82S
26. De Vriese AS, Van de, VJ, Lameire NH. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation. Kidney Int 2002; 61: 177-185
27. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 2000; 279: F965-F981
28. Busse R, Edwards G, Feletou M et al. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-380
29. Sofola OA, Knill A, Hainsworth R et al. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 2002; 543: 255-260
30. Waldron GJ, Ding H, Lovren F et al. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br J Pharmacol 1999; 128: 653-658
31. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905